baber/WOPTO huggingface dataset:
Patent DK-0519807-T3 (DK)
Inventor: CASTELLA SOLA JAUME
IPC: C07C201/12
Filed: 1992-06-16
Granted: 1995-12-18
Abstract: The invention relates to a process for the dehydrochlorination of 1,1-bis(R-phenyl)-2,2,2-trichloroethanes using an aqueous alkaline hydroxide solution, characterised in that the process is carried out in the absence of solvent and in the presence of a phase transfer agent.
Patent DK-0624157-T3 (DK)
Inventor: MONNIER JOHN ROBERT
IPC: C07B61/00
Filed: 1992-11-09
Granted: 1997-09-15
Abstract: Disclosed is a continuous process for the manufacture of 2,5-dihydrofurans by the isomerization of  gamma , delta -epoxyalkenes in the liquid phase in the presence of a catalyst system comprising an onium iodide compound and a Lewis acid and a process solvent comprising a mixture of the 2,5-dihydrofuran product of the process and an oligomer of the  gamma , delta -epoxyalkenes reactant.
Patent DK-0581146-T3 (DK)
Inventor: CASELLI GIANCARLO
IPC: C08F10/00
Filed: 1993-07-16
Granted: 1998-02-09
Abstract: Disclosed is a process for adding stabilizers and, optionally, additives to polyolefins in particle form obtained in liquid monomer by means of Ziegler-Natta catalysts, wherein the addition of stabilizers and, optionally, additives is carried out in liquid monomer in a step that follows polymerization, but precedes the flashing of the liquid monomer, after the aluminum alkyl has been deactivated.
Patent DK-0569338-T3 (DK)
Inventor: GONELLA JACQUES DR
IPC: A61K31/565
Filed: 1993-05-07
Granted: 1999-05-03
Abstract: The adhesive plaster for the transdermal administration of estradiol or mixture estradiol/ progestin is composed of an impermeable carrier film and of an adhesive composition. The latter represents a matrix or reservoir layer and is composed of a solvent-based polyacrylate or polyisobutylene adhesive which contains a saturated or unsaturated fatty acid with 6 to 18 C atoms as permeability enhancer, estradiol or mixture estradiol/progestin as active substance and optionally propylene glycol as solvent. The adhesive plaster is used for the systemic administration of hormones in hormone replacement therapy for a time of at least 3 days.
Patent DK-0566556-T3 (DK)
Inventor: WEIER RICHARD MATHIAS
IPC: C07D491/056
Filed: 1993-03-31
Granted: 1996-08-19
Abstract: Novel 2-alkyl carbinol derivatives of deoxynojirimycin (DNJ) and the chemical synthesis of these derivatives and intermediates therefor from DNJ and their use for inhibiting lentiviruses are disclosed. <CHEM>
Patent DK-0580829-T3 (DK)
Inventor: BAUER JACQUES
IPC: C12R1/19
Filed: 1993-02-03
Granted: 1998-08-10
Abstract: PCT No. PCT/CH93/00029 Sec. 371 Date Sep. 20, 1993 Sec. 102(e) Date Sep. 20, 1993 PCT Filed Feb. 3, 1993 PCT Pub. No. WO93/16190 PCT Pub. Date Aug. 19, 1993.An extract based on modified bacterial proteins includes a mixture of acid bacterial polyanions having a molecular weight in the range from 10,000 to 1,000,000 and an isoelectric point in the range from 2.5 to 5.5, and in which the added weights of the constituent amino acids amount to at least 50% of the extract. The preparation or this protein extract includes a cultivation of bacteria in an aqueous medium and then the alkaline extraction of this bacterial suspension and the purification of the protein extract. The alkaline extraction is carried out in the presence of a dilute aqueous source of OH- ions and at a stable pH in the range from 11 to 13, the decrease of this pH during the acid extraction not exceeding 0.4. The protein extract thus obtained can be used as an active ingredient in a pharmaceutical composition.
Patent DK-0773767-T3 (DK)
Inventor: KOLAR MILAN
IPC: A61F13/20
Filed: 1993-11-15
Granted: 2000-04-25
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent DK-0672142-T3 (DK)
Inventor: HOLLIGER KASPAR-PHILIPP
IPC: C12P21/02
Filed: 1993-12-03
Granted: 2001-06-18
Abstract: PCT No. PCT/GB93/02492 Sec. 371 Date May 14, 1996 Sec. 102(e) Date May 14, 1996 PCT Filed Dec. 3, 1993 PCT Pub. No. WO94/13804 PCT Pub. Date Jun. 23, 1994Polypeptides comprising a first domain, which comprises a binding region of an immunoglobulin heavy chain variable region, and a second domain, which comprises a binding region of an immunoglobulin light chain variable region, the domains being linked but incapable of associating with each other to form an antigen binding site, associate to form antigen binding multimers, such as dimers, which may be multivalent or have multispecificity. The domains may be linked by a short peptide linker or may be joined directly together. Bispecific dimers may have longer linkers. Methods of preparation of the polypeptides and multimers and diverse repertoires thereof, and their display on the surface of bacteriophage for easy selection of binders of interest, are disclosed, along with many utilities.
Patent DK-0706507-T3 (DK)
Inventor: YORK PETER
IPC: A61K9/16
Filed: 1994-06-30
Granted: 2000-04-10
Abstract: PCT No. PCT/GB94/01425 Sec. 371 Date Mar. 28, 1996 Sec. 102(e) Date Mar. 28, 1996 PCT Filed Jun. 30, 1994 PCT Pub. No. WO95/01324 PCT Pub. Date Jan. 12, 1995The present invention relates to particulate products which may be prepared by methods and apparatus using supercritical fluids. More particularly, the invention relates to pharmaceutical products, in particular easily handled and easily fluidized crystalline forms of salmeterol xinafoate, with controlled particle size and shape.
Patent DK-0665406-T3 (DK)
Inventor: JOHANSSON JOERGEN
IPC: F21V17/10
Filed: 1995-01-13
Granted: 1998-12-07
Abstract: A work piece (1) for a frame structure (29) for en electrical light fitting, designed to be recessed into a ceiling or wall opening, consists of a planar metal strip having mitre cuts (10,11), which are located at the ends of said strip and are mirror-symmetrically disposed in relation fo each other. In accordance with the invention transversal end surfaces (12,13) are located in connection with said mitre cuts at the ends (2,3) of the strip, the one of said end surfaces (12) being provided with an axially porjecting lock tongue (14) and the other of them (13) in close connection with an oblong hole (16), designed to receive the lock tongue. Also, the metal strip according to the invention is along its length provided with mirror-symmetrically disposed mitre cut pairs (10', 11'), in connection with which transversal end surfaces (12',13') are arranged, which are joined to each other by means of bridge portions, which form lock devices (23). Each lock device consists of a tongue (14') and a fork portion (19), which extends from the tongue and which , when the strip is folded about the symmetry plane, which extends through each mitre cut pair, is folded and is brought to abut on the outer side of one of the inner frame sides (30). The invention also relates to a frame structure, manufactured from such a work piece as well as a method to manufacture such a frame structure. <IMAGE>   <IMAGE>
Patent DK-0683082-T3 (DK)
Inventor: SEDELMEYER BARBARA DR
IPC: B61L21/06
Filed: 1995-03-30
Granted: 1998-10-07
Abstract: The function monitoring device has a data processor (UE) receiving all the inputs for the schematic track display (ST), with storage of the switch conditions of the signalling image elements. A stored list of permissible logic rules is held in the data processor for comparison with the actual switch conditions, to provide an indication when a non-permissible switch condition is detected. The data processor checks the validity of the non-permissible switch condition and provides a warning signal only if the checked indication is consistent. <IMAGE>
Patent DK-0687737-T3 (DK)
Inventor: ORLE KARINA ANNA
IPC: C12Q1/68
Filed: 1995-05-08
Granted: 2000-12-27
Abstract: The present invention provides methods and reagents for the detection and identification of four causative agents of genital ulcerations, herpes simplex virus (HSV) types 1 and 2, Treponema pallidum, and Haemophilus ducreyi. The methods use sequence-specific primers which enable the simultaneous polymerase chain reaction amplification of genomic nucleic acid sequences from HSV types 1 and 2, T. pallidum, and H. ducreyi. Following amplification, sequence-specific oligonucleotide probes are used to detect and distinguish HSV type 1 and 2, T. pallidum, and H. ducreyi nucleic acid.
Patent DK-0685544-T3 (DK)
Inventor: KAHL LOTHAR DR
IPC: B01F5/04
Filed: 1995-05-22
Granted: 2000-03-20
Abstract: The prodn. of aq. emulsion paints (I) based on binder resins with NCO reactive H atoms (II) and polyisocyanates (III) comprises mixing the components with water and forcing the mixt. through a nozzle with a small size in at least one dimension, under a pressure of 1-30 MPa. Also claimed are bimodal aq. emulsion paints based on OH gp. contg. resin binders (II) and (III), with a particle size distribution with one peak in the size range of 40-200 nm and a second peak in the range 200-2000 nm.
Patent DK-0717707-T3 (DK)
Inventor: BRILMAN GERRIT WILLEM
IPC: B65D17/32
Filed: 1994-11-01
Granted: 1998-06-02
Abstract: The invention relates to a container (1), for instance for a liquid, with a body (2) and an end wall (3) which is provided with a tiltable tab (4) for tilting in the end wall to form an opening (5), wherein the tiltable tab (4) is provided with a tab passage (8) such that in the tilted position the tiltable tab (4) bounds the opening (5) in the end wall (3) and connects with the tab passage (8) onto the opening, and that a tiltable tab portion (4) forms a pouring element (13) which extends at least as far as an end wall edge, and to an end wall (3) for a container body with a tiltable tab (4).
Patent DK-0705255-T3 (DK)
Inventor: GECZY JOSEPH
IPC: C07D295/30
Filed: 1995-04-25
Granted: 2000-12-11
Abstract: PCT No. PCT/HU95/00011 Sec. 371 Date Apr. 16, 1996 Sec. 102(e) Date Apr. 16, 1996 PCT Filed Apr. 25, 1995 PCT Pub. No. WO95/29172 PCT Pub. Date Nov. 2, 1995New inclusion complexes which are stable in their so-lid state formed of SIN-1A and cyclodextrins or cyclodextrin derivatives and optionally also containing ions as catalyst or stabilizer. The complexes release nitric oxide at room temperature upon dissolving in water or aqueous systems. The ions are preferably carboxylic acid anions such as acetate, formiate, propionate, ascorbinate, tartarate and/or lactate and/or inorganic acid anions such as phosphate, phosphite, borate, carbonate, hydrocarbonate, sulfate, sulfite and/or cations such as alkali and/or ammonium. Pharmaceutical compositions as well as kits containing the complexes. The kits are to be used as NO-liberating standards to release NO in a predictable amount and rate on dissolving in aqueous media. Processes for the preparation of the complexes by subjecting at a suitable pH SIN-1 to the catalytic action of ions to shift the equilibrium towards formation of SIN-1A in the presence of cyclodextrins or cyclodextrin derivatives capable to form inclusion complexes, whereby the SIN-1A formed is immediately complexed and stabilized and isolating in the solid state the obtained new complexes optionally containing ions. A preferred process includes reacting SIN-1 and a cyclodextrin or cyclodextrin derivative in the solid state in the presence of a salt as a catalyst by thoroughly admixing or milling the components together or by freeze drying an aqueous, oxygen-free solution containing the components, followed preferably by "second drying" in vacuo.
Patent DK-0759880-T3 (DK)
Inventor: SCHILLER ROLF
IPC: B65F3/00
Filed: 1995-05-19
Granted: 1998-08-10
Abstract: PCT No. PCT/DE95/00661 Sec. 371 Date Nov. 15, 1996 Sec. 102(e) Date Nov. 15, 1996 PCT Filed May 19, 1995 PCT Pub. No. WO95/32135 PCT Pub. Date Nov. 30, 1995A garbage collection and transport system, in which a garbage vehicle (1) has a horizontal partition (4) for forming two stowage spaces (5, 6) located one above the other, is proposed. So that different types of garbage containers (9) can be emptied, the garbage vehicle (1) has a loading trough (22) which extends the partition (4) and which can be positioned with its end edge (29) in such a way that it is adapted to that chamber (14, 15) of the garbage container (9) which is in each case to be separated off.
Patent DK-0759981-T3 (DK)
Inventor: ASKELOEF PER
IPC: C12P21/04
Filed: 1995-06-01
Granted: 2005-08-01
Abstract: PCT No. PCT/SE95/00628 Sec. 371 Date Apr. 21, 1997 Sec. 102(e) Date Apr. 21, 1997 PCT Filed Jun. 1, 1995 PCT Pub. No. WO95/33825 PCT Pub. Date Dec. 14, 1995A method of cultivating bacteria having genes in plasmids which code for surface or membrane bound antigens or other proteins and which are expressed in a temperature regulated manner for the production of desired bacterial products, is disclosed. The bacteria are first cultivated in a culture medium to an inoculum under such temperature conditions that the bacteria retain their plasmids and no expression occurs, e.g. 20 DEG  C., and then in a culture medium under such temperature conditions that expression occurs and before the bacteria lose their plasmids they are harvested, and the desired product is isolated.
Patent DK-0794942-T3 (DK)
Inventor: REITZ DAVID B
IPC: C07C311/29
Filed: 1995-11-29
Granted: 2000-08-14
Abstract: A class of terphenyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II:    <IMAGE>  II  wherein each of R2 and R3 is independently selected from hydrido and halo; or wherein R2 and R3 together form -OCH2O-; wherein each of R6 through R8 is independently selected from hydrido, lower alkyl, halo, lower alkoxy, lower haloalkyl, and lower dialkylamino; or wherein R6 and R7 together form -OCH2O; and wherein R12 is selected from lower alkylsulfonyl and aminosulfonyl; or a pharmaceutically-acceptable salt thereof.
Patent DK-0796257-T3 (DK)
Inventor: MORODER LUIS
IPC: C07F9/30
Filed: 1995-12-08
Granted: 2000-03-20
Abstract: There is described the use of a compound represented by general formulae (I), (II) or (III), for the inhibition of matrix metalloproteinases (MMP), wherein X1 is oxygen or sulfur, R1 is OH, SH, CH2OH, CH2SH or NHOH, R2 is a residue of 2 to 10 hydrocarbon backbone atoms, which binds to the amino acid 161 of HNC, said residue being saturated or unsaturated, linear or branched, and contains preferably homocyclic or heterocyclic structures, X2 is oxygen or sulfur and binds as hydrogen acceptor on amino acid 160 of HNC, Y is a residue which binds to the S1' pocket of HNC and consists of at least 4 backbone atoms Z1-Z2-Z3-Z4-R3, and R3 is n-propyl, isopropyl, isobutyl or a residue with at least 4 backbone atoms, which is not larger than a tricyclic ring system. These compounds bind to MMPs in a manner different from the mode of binding of the inhibitors of the state of the art.
Patent DK-0763952-T3 (DK)
Inventor: LOEBIG NORBERT DR RER NAT
IPC: H04Q3/545
Filed: 1996-08-26
Granted: 2004-12-27
Abstract: The method involves using a number of subscriber connection networks (A1...Am) that are connected to peripheral arrangements (LTG1...LTGn) of a communication system via a number of interfaces (S1...Sk). The communication system stores a number of data for each subscriber associated to a respective interface. Information is exchanged between the individual peripheral arrangements, and between the peripheral arrangements and a central control arrangement (CP) that stores subscriber related data. Each group of subscriber-related data that refer to subscribers connected to a common interface is stored in at least one peripheral arrangement.
Patent DK-0839703-T3 (DK)
Inventor: BERGMANN ERHARD
IPC: E05F15/16
Filed: 1996-11-02
Granted: 1999-04-19
Abstract: The hydraulic steering system has a supply pump (2) with the output directed through a control valve (3) that connects with the servo control steering circuit. This supplies fluid to a hydraulic steering servo actuator. The control circuit has a dispensing pump (14) that has different positions coupled to supply lines with restrictor elements (35) that connect with a common supply to the actuator and provide different rates of motion.
Patent DK-0805663-T3 (DK)
Inventor: SAMUELSEN PETER BOMAN
IPC: A61F13/02
Filed: 1996-01-26
Granted: 2000-12-18
Abstract: PCT No. PCT/DK96/00043 Sec. 371 Date Jul. 28, 1997 Sec. 102(e) Date Jul. 28, 1997 PCT Filed Jan. 26, 1996 PCT Pub. No. WO96/22754 PCT Pub. Date Aug. 1, 1996A dressing comprising a body facing layer of a thermoplastic adhesive and a carrier film and an absorbent material, the dressing having in itself an outwardly facing convex surface and an inwardly facing concave surface, wherein the dressing comprises a first area facing the wound or skin, the area having essentially three-dimensional geometry and optionally a second area, the first area preferably comprising a hydrocolloid adhesive and a carrier film, and the second area essentially showing adhesive properties and preferably comprising a carrier film and a hydrocolloid adhesive and wherein the adhesive in one or both areas is optionally covered by one or more layers to be removed before use.
Patent DK-0819004-T3 (DK)
Inventor: DAVE KAUSHIK J
IPC: A61K31/4439
Filed: 1996-03-29
Granted: 2009-11-30
Abstract: The present invention is concerned with an oral pharmaceutical formulation containing a proton pump inhibitor (PPI) which is suitable for the treatment of gastric acid related diseases in man and animals. More specifically, the composition is a paste, and is particularly suitable for delivery of a proton pump inhibitor to horses.
Patent DK-0828803-T3 (DK)
Inventor: VAN STEPHOUDT FRANZ
IPC: C05D9/00
Filed: 1996-04-26
Granted: 2000-02-07
Abstract: PCT No. PCT/DE96/00775 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Apr. 26, 1996 PCT Pub. No. WO96/38512 PCT Pub. Date Dec. 5, 1996The invention relates to a mineral vegetation substrate for agricultural or forestry use. The problem with prior art soil substrates based on recycled materials is that the usable field capacity is often insufficient or sufficient only with special additives. According to the invention, therefore, a mineral vegetation substrate consists of 45 to 65 wt. % geogenous sand and/or sandy soil with a grain size d50 of 0.20 to 0.35 mm, 4 to 8 wt. % coarse-grained crushed clay tiles with a grain size d50 of 25 to 35 mm, 8 to 18 wt. % fine-grained crushed clay tiles with a grain size d50 of 0.7 to 1.5 mm, 4 to 8 wt. % coarse-grained crushed concrete with a grain size d50 of 15 to 25 mm, 8 to 18 wt. % fine-grained crushed concrete with a grain size d50 of 1.5 to 3.5 mm, 8 to 13 wt. % binders like geogenous clay with a grain size d50 of 0.08 to 0.15 mm or clay in a homogenous mixture. The substrate is particularly suitable for soils poor in humus and for areas affected by forest fires and open-cast mining.
Patent DK-0880394-T3 (DK)
Inventor: MATACOTTA FRANCESCO CINO
IPC: C01G1/00
Filed: 1997-02-10
Granted: 2002-05-21
Abstract: Compounds having the formulawherein A is an alkaline-earth metal, an alkaline metal, a lanthanide, or a solid solution thereof, B is a transition metal, an element of group III, or a solid solution thereof, and d has a value between 0 and 1; a method for preparing the compounds; a method for producing composite materials on various matrices and thin or thick films deposited on various substrates which contain the compounds; their use; and a method for eliminating certain gases from a mixture that includes them by using the compounds.
Patent DK-1019516-T3 (DK)
Inventor: RECH FILHO ELIBIO LEOPOLDO
IPC: C12N15/82
Filed: 1997-10-07
Granted: 2004-09-27
Abstract: The present invention refers to a plant produced by a process of selecting germ line-transformed leguminous plants. The process includes introducing exogenous genes into apical meristematic cells of the embryonic axis of leguminous plants by bombarding the plant cells with a DNA construct which includes a sequence which encodes a protein capable of conferring tolerance to a herbicide selected from the group consisting of an imidazolinone and a glyphosate, inducing multiple shoot formation from the transformed cells by culturing the embryonic axis in a medium containing a cytokinin, and selecting the meristematic cell-derived shoots obtained by culturing the embryonic axis on a medium containing imidazolinone or glyphosate.
Patent DK-0893794-T3 (DK)
Inventor: YAMAGAMI TAMOTSU
IPC: G11B7/2407
Filed: 1998-07-22
Granted: 2005-11-07
Abstract: An optical recording medium capable of realizing high density and reliability in a recording/reproducing operation and facilitating the process which is performed by a drive apparatus is provided. The amplitude of an amount of wobbling of a track is made to be 10 nm to 15 nm and a track pitch of the track is made to be 0.74 µm to 0.82 µm. These values enable large-capacity recording to be realised and the recording/reproducing performance to be prevented from being deteriorated. As administration information, recommended information for a recording/reproducing operation at an inner peripheral position and an outer peripheral position is recorded. The size of data in a linking section is made to be the same as a sector for constituting a data block.
Patent DK-1007685-T3 (DK)
Inventor: KNUDSEN KATRINE
IPC: G01N33/569
Filed: 1998-06-19
Granted: 2006-08-14
Abstract: The invention relates to the identification of members of a gene family from the human respiratory pathogen Chlamydia pneumoniae, encoding surface exposed membrane proteins of a size of approximately 89-101 kDa, preferably about 89.6-100.3 kDa and about 56.1 kDa. The invention relates to the novel DNA sequences, the deduced amino acid sequences of the corresponding proteins and the use of the DNA sequences and the proteins in diagnosis of infections caused by C. pneumoniae, in pathology, in epidemiology, and as vaccine components.
Patent DK-1019039-T3 (DK)
Inventor: CAPELLA ROBERTO L
IPC: A61K47/36
Filed: 1998-09-16
Granted: 2002-03-25
Abstract: The present invention is directed to a stable nitroglycerin containing pharmaceutical composition, preferably a tablet which is prepared by direct compression technology. The formulation closely replicates the properties of nitroglycerin molded sublingual tablets (e.g. adequate disintegration and sublingual absorption), while reducing the problems experienced with compressed tablets (e.g. friability and weight variations). The stable tablets are characterized by a decreased migration of nitroglycerin, decreased potency loss, excellent content uniformity when stored. The preferred combination of components are: nitroglycerin/lactose dilution, hydrous lactose, glyceril monostearate, fumed silica, pregelantinized starch and calcium stearate. The preferred process employs direct compression technology to yield composition showing adequate disintegration, bioavailability and improved stability.
Patent DK-1048226-T3 (DK)
Inventor: KRATKY ZDENEK
IPC: A23L33/00
Filed: 1999-04-29
Granted: 2005-10-03
Abstract: An infant formula which contains a lipid source, a carbohydrate source, and a protein source. The protein source contains the free amino acids arginine, tyrosine, and histidine and a hydrolysed sweet whey fraction from which caseino-glyco-macropeptide has been removed. The infant formula is low in threonine and high intrypotophan. The infant formula may be a pre-term formula or a full-term hypoallergenic formula.